Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAT2A | P31153 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | CASP7 | P55210 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TDP2 | O95551 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | KLK7 | P49862 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23029028 | 0.84 | TP53 (0.32) | MAT2AKDM4EALDH1A1HPGD | |
| SCHEMBL21452053 | 0.81 | KDM4E (0.31) | MAT2AKDM4EALDH1A1GAA | |
| SCHEMBL21451755 | 0.80 | TDP2 (0.38) | MAT2AKDM4EALDH1A1TDP2 | |
| SCHEMBL23029041 | 0.79 | ALDH1A1 (0.38) | KDM4EALDH1A1GAAHPGD | |
| SCHEMBL21451741 | 0.79 | KDM4E (0.35) | MAT2AKDM4EALDH1A1 | |
| SCHEMBL24088811 | 0.79 | MAOB (0.33) | KDM4EALDH1A1GAAHPGDCASP1 | |
| SCHEMBL21452120 | 0.79 | ALDH1A1 (0.36) | KDM4EALDH1A1HPGDRECQLHSD17B10 | |
| SCHEMBL21452058 | 0.78 | KDM4E (0.33) | MAT2AKDM4EALDH1A1GAA | |
| SCHEMBL23029181 | 0.78 | KDM4E (0.41) | MAT2AKDM4EALDH1A1HSD17B10 | |
| SCHEMBL23029198 | 0.78 | TDP2 (0.35) | MAT2ATDP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210057650-A1 | AMINE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2021-02-25 | — | — | US | disclosed |
| WO-2019194617-A1 | AMINE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | 주식회사 엘지화학 | 2019-10-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210057650-A1 | AMINE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | DRD1, RNF10, DRD2 | MAT2A 1163/4885KDM4E 2073/4885ALDH1A1 216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.